A New Alzheimer’s Drug is Finally Here – Our Healthcare System is Far from Ready
The new year always brings hope, but this January that hope was palpable for the over 50 million people with Alzheimer’s Disease (AD) worldwide, their families, friends, and clinicians when the Food and Drug Administration (FDA) granted accelerated approval for Leqembi to treat mild cognitive impairment or dementia due to AD. For the first time, […]